Incidence, risk factors and prognosis of stroke and TIA: The need for high-quality, large-scale epidemiological studies and meta-analyses

Cerebrovascular Diseases

Volumn 16, Issue SUPPL. 3, 2003, Pages 2-10

  Rothwell, Peter M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Cholesterol; Hypertension; Stroke; Transient ischaemic attack

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CONFERENCE PAPER; GEOGRAPHIC DISTRIBUTION; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; LIFESTYLE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTEBROBASILAR INSUFFICIENCY;

CEREBROVASCULAR ACCIDENT; EPIDEMIOLOGIC STUDIES; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; META-ANALYSIS; PROGNOSIS; QUALITY OF HEALTH CARE; RISK FACTORS;

EID: 0038612838     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070271     Document Type: Conference Paper

References (99)

1. Bonita R: Epidemiology of stroke. Lancet 1992;339:342-344.
2. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD: The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123;665-676.
3. Rothwell PM: The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 2001;357:1612-1616.
4. Dippel D, Koudstaal PJ: We need stronger predictors of major vascular events in patients with a recent TIA or non-disabling stroke. Stroke 1997;28:774-776.
5. Sacco RL: Identifying patient populations at high risk of stroke. Neurology 1998;51(suppl 3):S27-S30.
6. Murray CJL, Lopez AD: Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-1276.
7. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-1986. 2. Incidence, case fatality and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:16-22.
8. Bonita R, Anderson C, Broad J, Jamrozik K, Stewart-Wynne E, Anderson N: Stroke incidence and case-fatality in Australasia: a comparison of the Auckland and Perth population-based stroke registers. Stroke 1994;25:552-557.
9. Bonita R, Broad J, Beaglehole R, Anderson N: Changes in incidence and case-fatality in Auckland, New Zealand, 1981-1991. Lancet 1993; 342:1470-1473.
10. Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG: Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study. Stroke 1994;25:1935-1944.
11. Anderson CS, Linto J, Stewart-Wynne E: A population-based assessment of the impact and burden of caring for long-term survivors of stroke. Stroke 1995;26:843-849.
12. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor W, Mayberg MR, Warlow CP, Barnett HJM, for the Carotid Endarterectomy Trialists' Collaboration: Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361(9352):107-116.
13. European Atrial Fibrillation Trial Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
14. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501.
15. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients. BMJ 2002;342:71-86.
16. Staessen JA, Gasowski J, Wang JG, Lutgarde T, Hond ED, Boissel J-P, Ekbom T, Gueyffier F, Lisheng L, Kerlikowske K, Pocock S, Fagard RH: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-872.
17. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
18. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
19. Ezzati M, Lopez AD, Rodgers A, Hoorn SV, Murray CJL, and the Comparative Risk Collaborating Group: Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360.
20. Kernan WN, Viscoli C, Brass LM, Makuch RW, Sarrel PM, Horwitz RI: Blood pressure exceeding national guidelines among women after stroke. Stroke 2000;31:415-419.
21. Joseph LN, Babikian VL, Allen NC, Winter MR: Risk factor modification in stroke prevention: experience of a stroke clinic. Stroke 1999;30:16-20.
22. Bonita R, Stewart A, Beaglehole R: International trends in stroke mortality: 1970-1985. Stroke 1990;21:989-992.
23. Stegmayr B, Asplund K: Exploring the declining case fatality in acute stroke. Population-based observations in the northern Sweden MONICA Project. J Intern Med 1996;240: 143-149.
24. Gillum RF, Sempos CT: The end of the long-term decline in stroke mortality in the United States. Stroke 1997;28:1527-1529.
25. Bonita R, Beaglehole R: Monitoring stroke: an international challenge. Stroke 1995;26:541-542.
26. Jamrozik K, Broadhurst RJ, Lai N, Hankey GJ, Burvill PW, Anderson CS: Trends in the incidence, severity, and short-term outcome of stroke in Perth, Western Australia. Stroke 1999;30:2105-2111.
27. McGowern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H: Trends in mortality, morbidity and risk factor levels for stroke from 1960-1990: the Minnesota Heart Survey. JAMA 1992;268:753-759.
28. Broderick JP: Stroke trends in Rochester, Minnesota, during 1945 to 1984. Ann Epidemiol 1993;3:476-479.
29. Chang CC, Chen CJ: Secular trend of mortality from cerebral infarction and cerebral hemorrhage in Taiwan, 1974-1988. Stroke 1993;24: 212-218.
30. Feigin VL, Wiebers DO, Whisnant JP, O'Fallon M: Stroke incidence and 30-day case fatality rates in Novosibirsk, Russia, 1982 through 1992. Stroke 1995;26:924-929.
31. Numminen H, Kotila M, Waltimo O, Aho K, Kaste M: Declining incidence and mortality rates of stroke in Finland from 1972 to 1991: results of 3 population-based stroke registers. Stroke 1996;27:1487-1491.
32. McGovern PG, Shahar E, Sprafka JM, Pankow JS: The role of stroke attack rate and case fatality in the decline of stroke mortality: the Minnesota Heart Survey. Ann Epidemiol 1993;3: 483-487.
33. Stegmayr B, Asplund K, Wester PO: Trends in incidence, case fatality rate, and severity of stroke in Northern Sweden, 1985-1991. Stroke 1994;25:1738-1745.
34. Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, Kannel WB: Secular trends in stroke incidence and mortality: the Framingham Study. Stroke 1992;23: 1551-1555.
35. Ryglewicz D, Polakowska M, Lechowicz W, Broda G, Roskiewicz M, Jasinski B, Hier DB: Stroke mortality rates in Poland did not decline between 1984 and 1992. Stroke 1997;28:752-757.
36. Terent A: Increasing incidence of stroke among Swedish women. Stroke 1988;19:598-603.
37. Jørgensen HS, Plesner A-M, Hübbe P, Larsen K: Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke 1992;23:1710-1704.
38. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27: 373-380.
39. WHO MONICA Project (prepared by Thorvaldsen P, Kuulasma K, Rajakangas AM, Rastenyte D, Sarti C, Wilhemsen L): Stroke trends in the WHO MONICA project. Stroke 1997; 28:500-506.
40. Malmgren R, Warlow C, Bamford J, Sandercock P: Geographical and secular trends in stroke incidence. Lancet 1987;2:1196-1200.
41. Sudlow CLM, Warlow CP: Comparing stroke incidence worldwide: What makes studies comparable? Stroke 1996;27:550-558.
42. The Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke. London: Royal College of Physicians, 2000.
43. Scottish Intercollegiate Guidelines Network. SIGN guidelines: Management of patients with stroke. Edinburgh: SIGN, 1997 (www.sign. ac.uk).
44. Feinberg WM, Albers GW, Barnett HJM, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW, Kronmal RA, Moore WS, Robertson JT: Guidelines for the management of transient ischaemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischaemic Attacks of the Stroke Council of the American Heart Association. Stroke 1994;25:1320-1335.
45. Johnston SC, Smith WS: Practice variability in management of transient ischaemic attacks. Eur Neurol 1999;42:105-108.
46. Gubitz G, Phillips S, Dwyer V: What is the cost of admitting patients with transient ischaemic attacks to hospital? Cerebrovasc Dis 1999;9: 210-214.
47. Warlow CP, Dennis MS, van Gijn J, Sandercock PAG, Bamford JM, Wardlaw JM: Preventing recurrent stroke and other serious vascular events. Stroke: a practical guide to management, pp 653-722. Oxford: Blackwell Science Ltd, 2001.
48. Hankey GJ: Impact of treatment of people with transient ischaemic attacks on stroke incidence and public health. Cerebrovasc Dis 1996;6 (suppl 1):26-33.
49. Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284: 2901-2906.
50. Lovett J, Dennis M, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM: The very early risk of stroke after a first transient ischaemic attack: Implications for public education. Stroke (in press).
51. Whisnant JP, Matsumoto N, Elveback LR: Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973;48:194-198.
52. Dennis M, Bamford J, Sandercock P, Warlow C: Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990;21:848-853.
53. Brown RD, Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP: Incidence of transient ischaemic attacks in Rochester, Minnesota, 1985-1989. Stroke 1998;29:2109-2113.
54. Feigin VL, Shishkin SV, Tzirkin GM, Vinogradova TE, Tarasov AV, Vinogradov SP, Nikitin YP: A population-based study of transient ischaemic attack incidence in Novosibirsk, Russia, 1987-1988 and 1996-1997. Stroke 2000;31:9-13.
55. Lemesle M, Milan C, Faivre J, Moreau T, Giroud M, Dumas R: Incidence trends of ischaemic stroke and transient ischaemic attacks in a well defined French population from 1985 through 1994. Stroke 1999;30:371-377.
56. Sempere AP, Duarte J, Cabezas C, Claveria LE: Incidence of transient ischaemic attacks and minor ischaemic strokes in Segovia, Spain. Stroke 1996;27:667-671.
57. Ricci S, Celani MG, La Rosa F, Vitali R, Duca E, Ferraguzzi R, Paolotti M, Seppoloni D, Caputo N, Chiurulla C, Scaroni R, Signorini E: A community-based study of incidence, risk factors and outcome of transient ischaemic attacks in Umbria, Italy: the SEPIVAC study. J Neurol 1991;238:87-90.
58. Hankey GJ, Slattery JM, Warlow CP: The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1991;54:793-802.
59. Farrell B, Godwin J, Richards S, Warlow C: The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-1054.
60. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or non-disabling stroke. The Dutch TIA Study Group. Stroke 1988;19: 512-517.
61. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
62. Department of Health: National service framework for older people. London, Department of Health, 2001 (www.doh.gov.uk/nsf).
63. Muuronen A, Kaste M: Outcome of 314 patients with transient ischaemic attacks. Stroke 1982;13:24-31.
64. Larsen BH, Sorensen PS, Marquardsen J: Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation. A 10-year follow-up study of 46 patients. JNNP 1990;53:1029-1033.
65. Ueda K, Kiyohara Y, Hasuo Y, Yanai T, Kawano H, Wada J, Kato I, Kajiwara E, Omae T, Fujishima M: Transient cerebral ischemic attacks in a Japanese community, Hisayama, Japan. Stroke 1987;18:844-848.
66. Clark T, Murphy M, Rothwell PM: Long-term risks of stroke, myocardial infarction, and vascular death in patients with a non-recent transient ischaemic attack. JNNP (in press).
67. The Dutch TIA Trial Study Group: Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. Stroke 1993;24:4-31.
68. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H: Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001;345: 1084-1090.
69. Rothwell PM, Warlow CP: Prediction of benefit from carotid endarterectomy in individual patients: a risk modelling study. Lancet 1999; 353:2105-2110.
70. Marshall J: The natural history of transient ischaemic cerebrovascular attacks. Q J Med 1964;33:309-324.
71. Bradshaw P, McQuaid P: The syndrome of vertebrobasilar insufficiency. Q J Med 1963;32: 279-296.
72. Turney T, Garraway WM, Whisnant JP: The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke 1984;15:790-794.
73. Cartlidge NE, Whisnant JP, Elveback LR: Carotid and vertebral-basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota. Mayo Clin Proc 1977;52:117-120.
74. Acheson J: Factors affecting the natural history of 'focal cerebral vascular disease'. Q J Med 1971;40:25-46.
75. Kernan WN, Feinstein MD, Brass LM: A methodological appraisal of research on prognosis after transient ischaemic attacks. Stroke 1991;22:1108-1116.
76. Flossmann E, Rothwell PM: Are vertebrobasilar territory TIA or minor strokes really more benign than carotid territory events? Cerebrovascular Diseases 2002;13(suppl 3):45.
77. Prospective Studies Collaboration: Cholesterol, diastolic BP, and stroke: 13,000 strokes in 450,000 people in 45 cohorts. Lancet 1995;346: 1647-1653.
78. Eastern Stroke and Coronary Heart Disease Collaborative Research Group: Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 2001;352:1801-1807.
79. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C, for the UK-TIA Group: Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996;313:147.
80. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L: Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 1993;3:493-499.
81. Davies MJ, Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373.
82. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-250.
83. Herman B, Schmitz PIM, Leyten ACM, van Luijk JH, Frenken CWGM, op de Coul AAW, Schulte BPM: Multivariate logistic analysis of risk factors for stroke in Tilburg, the Netherlands. Am J Epidemiol 1983;118:514-525.
84. Lindenstrom E, Boysen G, Nyboe J: Risk factors for stroke in Copenhagen, Denmark. I. Basic demographic and social factors. Neuroepidemiology 1993;12:37-42.
85. Spriggs DA, French JM, Murdy JM, Bates D, James OF: Historical risk factors for stroke: a case control study. Age Ageing 1990;19:280-287.
86. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G: Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 1987;317:521-526.
87. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Intracerebral hemorrhage versus infarction: stroke severity, risk factors, and prognosis. Ann Neurol 1995;38:45-50.
88. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP: Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994;272:33-36.
89. Truelsen T, Lindenstrom E, Boysen G: Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study. Stroke 1994;25:802-807.
90. Bogousslavsky J, Van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
91. Arboix A, Morcillo C, Garcia-Eroles L, Oliveres M, Massons J, Targa C: Different vascular risk factor profiles in ischemic stroke subtypes: a study from the 'Sagrat Cor Hospital of Barcelona Stroke Registry'. Acta Neurol Scand 2000;102:264-270.
92. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC, on behalf of the German Stroke Data Bank Collaborators: Risk factors, outcome and treatment in subtypes of ischemic stroke. The German Stroke Data Bank. Stroke 2001;32:2559-2566.
93. Lee BI, Nam HS, Heo JH, Kim DI: Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis 2001;12:145-151.
94. Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC: Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997;28:2507-2512.
95. Inzitari D, Eliasziw M, Gates P, Sharpe B, Chan RKT, Meldrum HE, Barnett HJM: The causes and risk of stroke in patients with asymptomatic internal carotid artery stenosis. NEJM 2000;342:1693-1700.
96. Sudlow CL, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997;28:491-499.
97. Giroud M, Lemesle M, Quantin C, Vourch M, Becker F, Milan C, Brunet-Lecomte P, Dumas R: A hospital-based and a population-based stroke registry yield different results: the experience in Dijon, France. Neuroepidemiology 1997;16:15-21.
98. Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
99. Altman DG, Royston P: What do we mean by validating a prognostic model? Stat Med 2000;19:453-473.